Ir al contenido
AusGrant
UE Abierta EU-FUNDING-PORTAL-HORIZON-HLTH-2023-CARE-08-01

European Partnership on Personalised Medicine

European Commission (EC) · Concurrencia competitiva · Horizon Europe

De un vistazo

European Partnership on Personalised Medicine es una ayuda a escala de la UE de tipo «Concurrencia competitiva» concedida por European Commission. Financiación: Hasta €37M. Solicitantes elegibles: Open to eligible organisations in EU Member States and Horizon Europe associated countries; consortium requirements vary by topic - see the official call conditions. La fecha límite de solicitud es el 20 de enero de 2027. Solicita a través del anuncio oficial en ec.europa.eu.

Importe
Hasta €37M
Plazo
20 de ene. de 2027
Tipo
Concurrencia competitiva
Estado
Abierta

El programa

With this JTC, EP PerMed will fund research projects in human health on Cell and Gene Therapies (CGT) for PM approaches. Proposals must focus on the development and validation of an innovative and novel CGT for PM.At least one of the following approaches must be employed:Somatic cell therapeutics;Gene therapeutics;Combined cell- and gene therapeutics;Novel biological products.For the entire scope, please consult the Call Text: https://www.eppermed.eu/funding-projects/calls/jtc2027/.

Quién puede solicitar

Open to eligible organisations in EU Member States and Horizon Europe associated countries; consortium requirements vary by topic - see the official call conditions.

Cómo solicitar

Apply through the EU Funding & Tenders portal; submission is electronic via the portal's Submission Service before the topic deadline.

Solicitar en la fuente oficial